InsidersTradesSigma
Kite Pharma, Inc.: insider trades · United States · SEC (Form 4)
Discover the full insider trade history of Kite Pharma, Inc., a publicly traded company based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Market capitalisation: €1.8bn. The latest transaction was disclosed on 16 February 2016 (Levée d'options). Among the most active insiders: Sproule Rizwana F. The full history is free.
46
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
36 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Kite Pharma, Inc. Strong Buy (bullish), based on 10 analysts. Average price target: US$57.10.
19Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 16 February 2016
Declarations46 total
18,750 sharesCommon StockSEC:0001209191-16-098979:0
18,750 sharesCommon StockSEC:0001209191-16-098979:1
1,900 sharesCommon StockSEC:0001209191-16-095879:0
1,900 sharesCommon StockSEC:0001209191-16-095879:1
9,000 sharesCommon StockSEC:0001209191-16-095525:0
2,499 sharesCommon StockSEC:0001209191-16-095525:1
4,938 sharesCommon StockSEC:0001209191-16-095525:2
1,410 sharesCommon StockSEC:0001209191-16-095525:3
153 sharesCommon StockSEC:0001209191-16-095525:4
8,100 sharesCommon StockSEC:0001209191-16-094259:0
2,500 sharesCommon StockSEC:0001209191-16-094259:1
2,700 sharesCommon StockSEC:0001209191-16-094259:2
2,800 sharesCommon StockSEC:0001209191-16-094259:3
100 sharesCommon StockSEC:0001209191-16-094259:4
5,500 sharesCommon StockSEC:0001209191-16-092245:0
645 sharesCommon StockSEC:0001209191-16-092245:1
264 sharesCommon StockSEC:0001209191-16-092245:2
700 sharesCommon StockSEC:0001209191-16-092245:3
3,527 sharesCommon StockSEC:0001209191-16-092245:4
1,054 sharesCommon StockSEC:0001209191-16-092245:5
645 sharesCommon StockSEC:0001209191-16-092246:2
3,166 sharesCommon StockSEC:0001209191-16-092246:3
1,918 sharesCommon StockSEC:0001209191-16-092246:4
800 sharesCommon StockSEC:0001209191-16-092246:5
2,767 sharesCommon StockSEC:0001209191-16-092246:6
25 of 46 declarations
About Kite Pharma, Inc.
Kite Pharma, Inc. is a biopharmaceutical company focused on developing cell therapies for cancer treatment. It is listed on the NASDAQ under the ticker symbol KITE.